Skip to content

Ciprofol and Remifentanil Co-Administration for Pediatric Bronchoscopy Under General Anesthesia: A Prospective Study

Ciprofol and Remifentanil Co-Administration for Pediatric Bronchoscopy Under General Anesthesia: A Prospective Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101665
Enrollment
Unknown
Registered
2025-04-28
Start date
2024-09-20
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Interventions

group of 3-7years old :Administering propofol combined with remifentanil for general anesthesia in children aged 3-7 who are undergoing bronchoscopy
group of 8-12years old:Administering propofol combined with remifentanil for general anesthesia in children aged 8-12 who are undergoing bronchoscopy

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1) Age: 3-12 years old. (2) Gender unrestricted. (3) American Society of Anesthesiologists (ASA) physical status Class I--II. (4) Normal preoperative electrocardiogram and liver and kidney function tests.

Exclusion criteria

Exclusion criteria: (1) Parents of pediatric patients who refuse to participate in the trial. (2) Body weight exceeds the standard weight by more than 20%. (3) History of congenital, hereditary, or psychiatric diseases. (4) History of drug and food allergies. (5) History of surgical trauma and behavioral disorders. (6) History of sedative and analgesic drug use. (7) Significant recent life changes at home (such as death of a family member, moving to a new home, changing kindergartens, etc.).

Design outcomes

Primary

MeasureTime frame
The ED50 and ED95 of propofol combined with 2ug/kg remifentanil for bronchoscopy in children aged 3-7 years old;The ED50 and ED95 of propofol combined with 2ug/kg remifentanil for bronchoscopy in children aged 8-12years old;

Secondary

MeasureTime frame
The success rate of general anesthesia induction for bronchoscopy in children aged 3-7 years old using propofol combined with 2ug/kg remifentanil;The success rate of general anesthesia induction for bronchoscopy in children aged 8-12 years old using propofol combined with 2ug/kg remifentanil;Vital signs(SpO2, HR, and MAP) in children aged 3-7 years old during bronchoscopy under the administration of propofol combined with 2ug/kg remifentanil;Vital signs(SpO2, HR, and MAP) in children aged 8-12 years old during bronchoscopy under the administration of propofol combined with 2ug/kg remifentanil;Recovery time in children aged 3-7 years old during bronchoscopy under the administration of propofol combined with 2ug/kg remifentanil;Recovery time in children aged 8-12 years old during bronchoscopy under the administration of propofol combined with 2ug/kg remifentanil;

Countries

China

Contacts

Public ContactZheng Shengxing

The Second Affiliated Hospital of Wenzhou Medical University

zsx0106014@163.com+86 138 5889 9373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026